Torrent currently owns 48.8% of JB Pharma and is awaiting SEBI approval for the merger. The company expects ₹400-450 crore in cost synergies over the next 2-3 years, of which 20% is likely to be realised in the current year.
Torrent currently owns 48.8% of JB Pharma and is awaiting SEBI approval for the merger. The company expects ₹400-450 crore in cost synergies over the next 2-3 years, of which 20% is likely to be realised in the current year.